Gobec M - Search Results

1

Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors.

Dernovšek J, Zajec Ž, Durcik M, Mašič LP, Gobec M, Zidar N, Tomašič T. Dernovšek J, et al. Among authors: gobec m. Pharmaceutics. 2021 Aug 17;13(8):1283. doi: 10.3390/pharmaceutics13081283. Pharmaceutics. 2021. PMID: 34452244 Free PMC article.

2

Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol.

Gobec M, Tomašič T, Markovič T, Mlinarič-Raščan I, Dolenc MS, Jakopin Ž. Gobec M, et al. Chem Biol Interact. 2015 Oct 5;240:200-7. doi: 10.1016/j.cbi.2015.08.018. Epub 2015 Aug 31. Chem Biol Interact. 2015. PMID: 26335192

3

Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase.

Sosič I, Anderluh M, Sova M, Gobec M, Mlinarič Raščan I, Derouaux A, Amoroso A, Terrak M, Breukink E, Gobec S. Sosič I, et al. Among authors: gobec m, gobec s. J Med Chem. 2015 Dec 24;58(24):9712-21. doi: 10.1021/acs.jmedchem.5b01482. Epub 2015 Dec 3. J Med Chem. 2015. PMID: 26588190

4

Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.

Keček Plešec K, Urbančič D, Gobec M, Pekošak A, Tomašič T, Anderluh M, Mlinarič-Raščan I, Jakopin Ž. Keček Plešec K, et al. Among authors: gobec m. Bioorg Med Chem. 2016 Nov 1;24(21):5221-5234. doi: 10.1016/j.bmc.2016.08.044. Epub 2016 Aug 24. Bioorg Med Chem. 2016. PMID: 27601373

5

Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties.

Gobec M, Tomašič T, Štimac A, Frkanec R, Trontelj J, Anderluh M, Mlinarič-Raščan I, Jakopin Ž. Gobec M, et al. J Med Chem. 2018 Apr 12;61(7):2707-2724. doi: 10.1021/acs.jmedchem.7b01052. Epub 2018 Mar 22. J Med Chem. 2018. PMID: 29543461

6

Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition.

Loi EM, Weiss M, Pajk S, Gobec M, Tomašič T, Pieters RJ, Anderluh M. Loi EM, et al. Among authors: gobec m. Molecules. 2020 Jul 25;25(15):3381. doi: 10.3390/molecules25153381. Molecules. 2020. PMID: 32722493 Free PMC article.

7

New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth.

Weiss M, Loi EM, Sterle M, Balsollier C, Tomašič T, Pieters RJ, Gobec M, Anderluh M. Weiss M, et al. Among authors: gobec m. Front Chem. 2021 Apr 14;9:666122. doi: 10.3389/fchem.2021.666122. eCollection 2021. Front Chem. 2021. PMID: 33937202 Free PMC article.

8

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening.

Loi EM, Tomašič T, Balsollier C, van Eekelen K, Weiss M, Gobec M, Alteen MG, Vocadlo DJ, Pieters RJ, Anderluh M. Loi EM, et al. Among authors: gobec m. Molecules. 2022 Mar 19;27(6):1996. doi: 10.3390/molecules27061996. Molecules. 2022. PMID: 35335358 Free PMC article.

9

In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors.

Zajec Ž, Dernovšek J, Gobec M, Tomašič T. Zajec Ž, et al. Among authors: gobec m. Biomolecules. 2022 Jun 24;12(7):884. doi: 10.3390/biom12070884. Biomolecules. 2022. PMID: 35883440 Free PMC article.

10

Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma.

Zajec Ž, Dernovšek J, Distel M, Gobec M, Tomašič T. Zajec Ž, et al. Among authors: gobec m. Bioorg Chem. 2023 Feb;131:106311. doi: 10.1016/j.bioorg.2022.106311. Epub 2022 Dec 5. Bioorg Chem. 2023. PMID: 36495678 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page